SUBSCRIBE
SUBSCRIBE

Spyre Therapeutics

NEWS
Business
New CEOs Named in BioSpace’s Biopharma Movers and Shakers for July 23
It’s been a busy week for biopharma companies to name a chief executive officer. Over the past week, multiple companies have selected individuals to hold the top spots and guide the growth strategies of their companies.
July 23, 2018
 · 
4 min read
 · 
Alex Keown
Arthrex to Create 1,000 Jobs With New $74M Facilit
Drug Development
Aeglea BioTherapeutics Updates Phase I/II Trial Data
Aeglea BioTherapeutics announced new repeat dose data from its Phase I/II trial of AEB1102 (pegzilarginase) in patients with Arginase 1 Deficiency.
March 13, 2018
 · 
3 min read
 · 
Mark Terry
Everything's Bigger in Texas: Aeglea Biotherapeutics Quickly Growing into Leading Austin Biotech
Lone Star Bio
Everything’s Bigger in Texas: Aeglea Quickly Growing into Leading Austin Biotech
September 13, 2016
 · 
4 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
 · 
15 min read
 · 
Mark Terry
What You Need to Know About Aeglea
Business
What You Need to Know About Aeglea
December 2, 2015
 · 
5 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Eli Lilly,Novartis AG-Backed Startup, Aeglea, Nabs $44 Million
March 23, 2015
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Press Releases
Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for SPY001, its Novel Half-Life Extended Anti-α4β7 Antibody for the Treatment for Inflammatory Bowel Disease on November 12, 2024
November 12, 2024
 · 
1 min read
Press Releases
Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 8, 2024
 · 
15 min read
Press Releases
Spyre Therapeutics to Participate in Upcoming November 2024 Investor Conferences
October 31, 2024
 · 
1 min read
Press Releases
Spyre Therapeutics Announces Expected Acceleration of SPY003 (IL-23p19) Clinical Timelines and Presentations at UEGW supporting Spyre’s Portfolio of Potentially Best-in-Class Antibodies and Combinations
October 15, 2024
 · 
7 min read
Press Releases
Spyre Therapeutics Appoints Dr. Sheldon Sloan as Chief Medical Officer
October 1, 2024
 · 
5 min read
Business
Spyre Therapeutics to Participate in Upcoming Investor Conference
September 10, 2024
 · 
1 min read
Business
Spyre Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 7, 2024
 · 
14 min read
Genetown
Spyre Therapeutics Announces Grants of Inducement Awards - June 03, 2024
June 3, 2024
 · 
1 min read
Genetown
Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
 · 
1 min read
Business
Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr. Sandra Milligan to its Board of Directors
May 15, 2024
 · 
5 min read
Load More